“Chronic Neuropathy Pain Epidemiology” report has been recently added to DelveInsight

 

About Chronic Neuropathy Pain

Neuropathic pain is caused by a lesion or disease of the somatosensory system, including peripheral fibres (Aβ, Aδ and C fibres) and central neurons, and affects 7–10% of the general population. Multiple causes of neuropathic pain have been described and its incidence is likely to increase owing to the ageing global population, increased incidence of diabetes mellitus and improved survival from cancer after chemotherapy. Neuropathic pain may result from disorders.

 

Request for free sample copy of Chronic Neuropathy Pain Epidemiology Report- https://www.delveinsight.com/sample-request/chronic-neuropathic-pain-epidemiology-forecast

 

Chronic Neuropathy Pain Epidemiology

Neuropathic pain is characterized by a “pain arising as a direct consequence of a lesion or disease of the somatosensory system”. The existing literature has primarily investigated the epidemiology of neuropathic pain within the context of specific diseases, such as cancer, diabetic peripheral neuropathy (DPN), and chronic low-back pain (CLBP). The study by Bouhassira et al. (2019), have shown that the prevalence of neuropathic pain in the general population may be as high as 7–8%, accounting for 20–25% of individuals with chronic pain.

 

Important facts of Chronic Neuropathy Pain Epidemiology Report

• Chronic neuropathic pain is more frequent in women (8% vs. 5.7% in men) and in patients >50 years of age (8.9% vs. 5.6% in those 12,000 patients with chronic pain with both nociceptive and neuropathic pain types, referred to pain specialists in Germany, revealed that 40% of all patients experience at least some characteristics of neuropathic pain.
• A study of German population has shown that in general 6.5% of respondents have reported pain with chronic neuropathic pain characteristics, and have reported higher intensity and more interference of pain in their daily activities as compared to individuals with chronic non-neuropathic pain.
• “Neuromodulation Management of Chronic Neuropathic Pain in the Central Nervous System,” chronic neuropathic pain is a widespread condition that affects 7–8% of the total population.

 

Chronic Neuropathy Pain Diagnosis

Neuropathic pain may result from disorders of the peripheral nervous system or the central nervous system (brain and spinal cord). Thus, neuropathic pain may be divided into peripheral neuropathic pain, central neuropathic pain, or mixed (peripheral and central) neuropathic pain. Examples of the peripheral neuropathic pain include diabetic peripheral neuropathy (DPN), postherpetic neuralgia (PHN), antineoplastic therapy or HIV-induced sensory neuropathy, tumor infiltration neuropathy, phantom limb pain, postmastectomy pain, complex regional pain syndromes (reflex sympathetic dystrophy), and trigeminal neuralgia.

 

Chronic Neuropathy Pain Treatment

The treatment initially focuses on resolving the underlying cause. Medications used to treat neuropathic pain include over-the-counter analgesics, anticonvulsants, tricyclic antidepressants (TCAs), topical anesthetic agents, nonsteroidal anti-inflammatory drugs (NSAIDs), antiarrhythmics, narcotic analgesics, and opioids.

 

Chronic Neuropathy Pain Epidemiology: Report Scope

• The Chronic Neuropathic Pain report covers a detailed overview explaining its causes, symptoms, and classification, pathophysiology, diagnosis and treatment patterns
• The Chronic Neuropathic Pain Epidemiology Report and Model provide an overview of the risk factors and global trends of Chronic Neuropathic Pain in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
• The report provides insight about the historical and forecasted patient pool of Chronic Neuropathic Pain in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
• The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of Chronic Neuropathic Pain
• The report provides the segmentation of the Chronic Neuropathic Pain epidemiology

 

Request for free sample copy of Chronic Neuropathy Pain Epidemiology Report- https://www.delveinsight.com/sample-request/chronic-neuropathic-pain-epidemiology-forecast

 

Following is the table of content of Chronic Neuropathy Pain Epidemiology Report

1. Key Insights 

2. Executive Summary of Chronic Neuropathic Pain

3. Chronic Neuropathic Pain: Disease Background and Overview

4. Patient Journey

5. Epidemiology and Patient Population

6. Treatment Algorithm, Current Treatment, and Medical Practices

7. KOL Views

8. Unmet Needs

9.  Appendix

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

 

What are the reasons to buy?

• Develop business strategies by understanding the trends shaping and driving the global Chronic Neuropathic Pain market
• Quantify patient populations in the global Chronic Neuropathic Pain market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Chronic Neuropathic Pain therapeutics in each of the markets covered
• Understand the magnitude of Chronic Neuropathic Pain population by its epidemiology
• The Chronic Neuropathic Pain Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

 

Related Report

• Chronic Neuropathic Pain Market

 

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/